Post-transplant lymphoproliferative disorders: implications for acquired immunodeficiency syndrome-associated malignancies.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of the National Cancer Institute. Monographs

• Publication date

  2000-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A024255PMID 11158205
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Literature abstracts

  2004influential reference
• Dose-Adjusted EPOCH Chemotherapy (CT) in Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma (HIV-NHL): Preliminary Report of Efficacy, Immune Reconstitution, and HIV Control Following Therapy.

  1999cited by this paper
• Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients.

  1998cited by this paper
• BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome.

  1998cited by this paper
• Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients.

  1998cited by this paper
• Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome.

  1998cited by this paper
• Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients.

  1997cited by this paper
• Biology and adoptive cell therapy of Epstein‐Barr virus‐associated lymphoproliferative disorders in recipients of marrow allografts

  1997cited by this paper
• Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop.

  1997cited by this paper
• Factors affecting survival after orthotopic liver transplantation in infants.

  1997cited by this paper
• BCL-2 but not its Epstein-Barr virus-encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disorders.

  1996cited by this paper
• Are post-transplant lymphomas inevitable?

  1996cited by this paper
• Posttransplant T-cell lymphoproliferative disorders--an aggressive, late complication of solid-organ transplantation.

  1996cited by this paper
• Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders.

  1995cited by this paper
• Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin.

  1995cited by this paper
• Aggressive treatment for postcardiac transplant lymphoproliferation.

  1995cited by this paper
• Molecular genetic analysis demonstrates that multiple posttransplantation lymphoproliferative disorders occurring in one anatomic site in a single patient represent distinct primary lymphoid neoplasms

  1995cited by this paper
• Pretransplantation assessment of the risk of lymphoproliferative disorder.

  1995cited by this paper
• Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin.

  1995cited by this paper
• Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center.

  1995cited by this paper
• Early identification of Epstein‐Barr virus‐associated post‐transplantation lymphoproliferative disease

  1995cited by this paper
• Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.

  1995cited by this paper
• The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders.

  1995cited by this paper
• Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation.

  1995cited by this paper
• Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders

  1995cited by this paper
• Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients.

  1994cited by this paper
• Lymphoproliferative disorders and other tumors complicating immunodeficiencies.

  1994cited by this paper
• Posttransplant t‐cell lymphoma. Report of three cases and a review of the literature

  1994cited by this paper
• Clonal analysis of posttransplant lymphoproliferative disorders, using both episomal Epstein-Barr virus and immunoglobulin genes as markers.

  1994cited by this paper
• Clinical characteristics of post-transplant lymphoproliferative disorders.

  1994influential reference
• Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.

  1994cited by this paper
• Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.

  1994cited by this paper
• Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders.

  1993cited by this paper
• Cancer in AIDS

  1993cited by this paper
• Cancer in AIDS.

  1992cited by this paper
• Prevalence of Epstein-Barr virus and human papillomavirus in oral mucosa of HIV-infected patients.

  1992cited by this paper
• Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease.

  1992cited by this paper
• The changing pattern of posttransplant malignancies.

  1991cited by this paper
• Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression.

  1991cited by this paper
• Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.

  1991cited by this paper
• Cancer in the immunosuppressed organ recipient.

  1991cited by this paper
• Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients.

  1990influential reference
• Cancer in AIDS.

  1989cited by this paper
• Confirmation of the heterogeneity of posttransplant Epstein-Barr virus-associated B cell proliferations by immunoglobulin gene rearrangement analyses.

  1989cited by this paper
• Molecular genetic analysis of lymphoid tumors arising after organ transplantation.

  1989cited by this paper
• Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia.

  1989cited by this paper
• The diagnosis and treatment of posttransplant lymphoproliferative disorders.

  1988influential reference
• THE FREQUENCY OF EPSTEIN‐BARR VIRUS INFECTION AND ASSOCIATED LYMPHOPROLIFERATIVE SYNDROME AFTER TRANSPLANTATION AND ITS MANIFESTATIONS IN CHILDREN

  1988cited by this paper
• Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin.

  1988cited by this paper
• Epstein-Barr virus lymphoproliferation after bone marrow transplantation.

  1988cited by this paper
• Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation.

  1988cited by this paper
• Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus.

  1988cited by this paper
• The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.

  1988cited by this paper
• Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients. Clonal analysis based on immunoglobulin-gene rearrangements.

  1984cited by this paper
• Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.

  1983cited by this paper
• Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation.

  1982cited by this paper
• Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients.

  1981cited by this paper

• Rheumatoid arthritis, methotrexate, and lymphoma: risk substitution, or cat and

  2017cites this paper
• Bloodstream Infections

  2016cites this paper
• Epstein- Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of Oncogenesis

  2015cites this paper
• Role of Immune Escape Mechanisms in Hodgkin's Lymphoma Development and Progression: A Whole New World with Therapeutic Implications

  2012cites this paper
• Overview of the Large DNA Tumor Viruses

  2009cites this paper
• Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom.

  2009cites this paper
• Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis.

  2007cites this paper
• Safety of Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis

  2007cites this paper
• Viruses and lymphoma/leukaemia

  2006cites this paper
• Rituximab (Chimeric Anti-CD20 Antibody) for Posttransplant Lymphoproliferative Disorder after Solid Organ Transplantation in Adults: Long-Term Experience from a Single Center

  2005cites this paper
• Mechanisms of the self/non-self-survey in the defense against cancer: potential for chemoprevention?

  2005cites this paper
• Immunomodulation and Safety of Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis

  2005cites this paper
• Peripheral T Cell Lymphoma with Cytotoxic Phenotype: An Emerging Disease in HIV-Infected Patients?

  2004cites this paper
• Lymphoproliferative disease associated with immune deficiency in children.

  2004cites this paper
• mouse with Epstein-Barr virus ? Rheumatoid arthritis , methotrexate , and lymphoma : risk substitution , or cat and

  2004cites this paper
• Cardiac transplant experience with cyclosporine.

  2004cites this paper
• Resolution of AIDS-related Castleman's Disease with Anti-CD20 Monoclonal Antibodies is Associated with Declining IL-6 and TNF-α Levels

  2004cites this paper
• Incidence of novel N‐glycosylation sites in the B‐cell receptor of lymphomas associated with immunodeficiency

  2004cites this paper
• Lesions Due to Radiation

  2003cites this paper
• Treatment of postrenal transplantation lymphoproliferative disease manifesting as plasmacytoma with nonmyeloablative hematopoietic stem cell transplantation from the same kidney donor

  2003cites this paper
• Interferon-γ Control of EBV-Transformed B Cells: A Role for CD8+ T Cells That Poorly Kill EBV-Infected Cells

  2002cites this paper
• Simian AIDS-Related Lymphoma Growth in Severe Combined Immunodeficiency Mice Is Independent of Karyotypic Abnormalities or Bcl-6 Mutations

  2002cites this paper
• Therapeutic challenges of AIDS-related non-Hodgkin's lymphoma in the United States and East Africa.

  2002cites this paper
• Rheumatoid arthritis, methotrexate, and lymphoma: risk substitution, or cat and mouse with Epstein-Barr virus?

  2001cites this paper